Literature DB >> 27621121

Incidence and risk factors of poststroke depression in patients with acute ischemic stroke: A 1-year prospective study in Taiwan.

Ching-Shu Tsai1, Chen-Long Wu2, Tai-Hsin Hung1, Shih-Yong Chou1, Jian-An Su3.   

Abstract

BACKGROUND: Poststroke depression (PSD) is one of the most frequent and devastating neuropsychiatric consequences of stroke. The purpose of this study was to investigate the incidence and risk factors for PSD in a general hospital in Taiwan.
METHODS: One hundred and one patients with ischemic stroke were enrolled initially, and 91 (90.1%) completed the 1-year study. Assessments were performed at baseline, and at the 1st, 3rd, 6th, 9th, and 12th month after enrolment. The definition of PSD was in accordance with the diagnostic criteria of major depressive episode in the Diagnostic and Statistical Manual, fourth edition (DSM-IV).
RESULTS: The accumulated incidence rates of PSD at the 1st, 3rd, 6th, and 9th, month were 4%, 8%, 9%, and 10%, respectively, and the overall incidence at 1 year was 11%. In multivariate regression analysis, female gender, higher depression score, and severity of stroke were significant risk factors. In subgroup analysis, a higher depression score was significantly associated with PSD, regardless of gender; however, stroke severity was a risk factor only in the female group.
CONCLUSION: The 1-year incidence of PSD was 11%, based on the DSM-IV diagnostic criteria. More attention should be paid to patients with more risk factors to enable earlier detection and intervention.
Copyright © 2016 Chang Gung University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Incidence; Poststroke depression; Risk factors; Taiwan

Mesh:

Year:  2016        PMID: 27621121      PMCID: PMC6140301          DOI: 10.1016/j.bj.2015.10.004

Source DB:  PubMed          Journal:  Biomed J        ISSN: 2319-4170            Impact factor:   4.910


At a glance commentary

Scientific background on the subject

Poststroke depression (PSD) is a very frequent neuropsychiatric sequel after ischemic stroke. Patients suffering from PSD may be associated with increased disability, poor rehabilitation outcome, and higher mortality. Thus, research into the incidence of PSD and the possible risk factors are important.

What this study adds to the field

Our study recruited ischemic stroke patients and followed them for 1 year to investigate the incidence of poststroke depression (PSD) and its risk factors. We used strict diagnostic criteria for PSD rather than just using the depression screening scale. Our result is valuable for the epidemiological study of PSD in Taiwan and useful also for its clinical implications. Depression is one of the most frequent neuropsychiatric consequences of stroke and affects about one-third of all stroke patients [1]. Patients who develop depression after acute stroke (so-called poststroke depression [PSD]) have been associated with increased disability, cognitive impairment, and risk of falls [2], [3], [4]. Patients with PSD have also been reported to have a stronger correlation with significant impairment, poor rehabilitation outcome, poor quality of life, and higher mortality than those without significant depressive symptoms [5], [6]. Cultural variations have been reported in the incidence and prevalence of functional depression among the general population [7], and this appears to be true for PSD, with reported prevalence rates ranging from 6% to 79% [8]. In ethnic Chinese populations, the reported prevalence rates of PSD were 16.4% and 17.2% in Hong Kong [9], [10], [11], 34.9% [12] and 62.2% [13] in Taiwan, 43.4% in China [14], and 55% in Singapore [15]. Variations in the peak incidence of PSD have also been reported, including an increased frequency in the initial weeks poststroke, and particularly within the first 3 months [16], [17], [18]; a peak incidence around the 3rd to 6th month after stroke has also been reported [19]. In spite of these inconsistencies in peak incidence, PSD has been reported to occur from the acute phase to at least 2–3 years [20] but with an apparent peak within the first 6 months after stroke [21]. In addition to its high incidence and prevalence, previous studies have reported various risk factors for PSD including gender, age, living alone, lesion location, stroke severity, and functional disability [22], [23], [24], [25]. Previous studies on the incidence and risk factors for PSD in Taiwan have focused on patients in outpatient departments and in the community rather than at the acute stage after stroke. Thus, the current study had 2 aims: (1) To survey the 12-month incidence of PSD among Taiwanese acute ischemic stroke patients, (2) to identify the risk factors associated with PSD.

Methods

Patient enrolment and assessment

This study was conducted from July 2007 to June 2010 in a general teaching hospital with 650 beds in Taiwan. All subjects were screened consecutively when they were admitted to the neurological ward. Patients were included if they had a diagnosis of the first or recurrent ischemic stroke that was image-proven and that had occurred within the past 4 weeks. Patients were excluded from the study if they: (1) Had a transient ischemic attack; (2) had impaired communication or cognitive function (Mini-Mental State Examination [MMSE] score <15); (3) had history of depression, psychosis, or severe substance abuse; (4) had been taking antidepressants within 2 weeks prior to the stroke; or (5) had possible concurrent depression. The onset of stroke was defined as the occurrence of abnormal neurological symptoms based on the patient's statements. The follow-up period was 12 months after enrolment. The first visit (baseline) was the patient's admission due to ischemic stroke. The initial assessments included recording demographic data, and an initial clinical diagnostic interview to exclude history of depression, concurrent depression, substance abuse, or psychosis. A self-report assessment scale for depression, the Taiwanese depression questionnaire (TDQ), was used to assess the severity of depressive symptoms. The TDQ is a 4-point scale with 18 items that has been shown to be a culturally specific depression screening instrument effective in screening depressive symptoms in Taiwanese with satisfactory reliability and validity [26]. It has also been reported to be superior to the Beck Depression Inventory in screening depression in a medical setting in Taiwan [27]. In addition, the National Institute of Health Stroke Scale (NIHSS) [28], instrumental activities of daily living scale (IADL) [29] and the MMSE [30] were used at the first visit.

Study protocol and diagnosis of poststroke depression

After being enrolled, the patients were followed up at the 1st, 3rd, 6th, 9th, and 12th month, and a clinical diagnostic interview was performed at each visit. The diagnosis of PSD in the study was based on the diagnostic criteria of major depressive episode in the Diagnostic and Statistical Manual, fourth edition (DSM-IV), and was made by a certificated psychiatrist (JA Su). If a patient dropped out, the reason was clarified and recorded.

Ethical review and informed consent

This study and the informed consent form were approved by the Institutional Review Board (IRB) of Chang Gung Memorial Hospital and were performed in accordance with the World Medical Association Declaration of Helsinki and the Good Clinical Practice guidelines. All the participants had sufficient mental capacity and written informed consents were obtained from the participants following a complete explanation and consideration.

Statistical analysis

The t-test and Chi-square test were used to compare differences between those with and without PSD. The cumulative incidence curve of PSD was plotted using Kaplan–Meier Method and the effects of risk factors were compared with the log-rank test. Univariate and multivariate Cox proportional hazard analyses were further used to determine the risk factors for PSD. A p < 0.05 was used to indicate statistical significance. All analyses were performed using SPSS for Windows, Version 18 (SPSS Inc., Chicago, IL, USA).

Results

Socio-demographic and clinical profiles

A total of 519 patients admitted to our neurological wards due to ischemia during the study period were screened; 101 fulfilled the enrolment criteria and agreed to participate in the trial. Of these 101 patients, 69 (68.3%) were male, and 84 (82.2%) were married. The TDQ, NIHSS, IADL, and MMSE scores at baseline are shown in Table 1.
Table 1

Baseline demographic data and clinical assessment scores.

Characteristicsn (%) or mean ± SD (n = 101)
Gender
 Female32 (31.7)
 Male69 (68.3)
Age (years)64.6 ± 11.0
Marital status
 Single3 (3.0)
 Married84 (82.2)
 Widowed/divorced14 (14.8)
Occupation
 None46 (45.5)
 Farmer and fisher27 (26.7)
 Others28 (27.7)
Educational level
 None29 (28.7)
 Primary school45 (44.6)
 Higher than secondary school27 (26.7)
Location of stroke
 Left hemisphere47 (47.5)
 Right hemisphere52 (52.5)
TDQ6.1 ± 5.9
NIHSS2.6 ± 2.8
IADL13.7 ± 7.5
MMSE25.0 ± 4.0
Completion rate91 (90.1)

Abbreviations: SD: Standard deviation; TDQ: Taiwanese Depression Screening Questionnaire; NIHSS: National Institutes of Health Stroke Scale; IADL: Instrumental activities of daily living scale; MMSE: Mini-mental status examination; PSD: Poststroke depression.

Baseline demographic data and clinical assessment scores. Abbreviations: SD: Standard deviation; TDQ: Taiwanese Depression Screening Questionnaire; NIHSS: National Institutes of Health Stroke Scale; IADL: Instrumental activities of daily living scale; MMSE: Mini-mental status examination; PSD: Poststroke depression. Ninety-one patients (90.1%) completed the 12 months of the study. There were no significant differences in baseline socio-demographic data or assessment scores between the patients who did and did not complete the study. The reasons for withdrawal from the study were unwillingness to participate (40%) and inability to cooperate with the study protocol (20%).

Incidence of poststroke depression

During the 12-month study period, 10 patients developed PSD; 4 were found at the 1st month visit, 3 at the 3rd month visit, and 1 each at the 6th, 9th, and 12th month visit after being enrolled. The incidence rates of PSD at the 1st, 3rd, 6th, and 9th month were 4%, 8%, 9%, and 10%, respectively, and the overall incidence at 1 year was 11% [Fig. 1].
Fig. 1

Incidences of poststroke depression.

Incidences of poststroke depression.

Risk factors for poststroke depression

The effects quartile classification of age, TDQ, NIHSS, IADL, and MMSE and other factors on PSD incidence were compared using log-rank test. Gender, TDQ, and NIHSS showed significant effects in Table 2. Further univariate Cox analysis revealed that PSD was significantly associated with female gender, higher TDQ and NIHSS scores, and a lower IADL score [Table 3]. After multivariate Cox regression analysis, female gender and higher TDQ and NIHSS scores still had a significant correlation [Table 3]. When the patients were divided into two groups based on gender, a higher TDQ score was significantly associated with PSD, regardless of gender. However, higher NIHSS scores, which were significantly associated with PSD, were observed only in the female group. The MMSE score may have been a protective factor for PSD in the male group; however, the significance disappeared after adjusting for the TDQ [Table 4].
Table 2

The related incidences of PSD by different demographic data and clinical assessment scores.

CharacteristicsPSD incidence n (%)pa
1-year incidence of PSD10/91 (11.0)
Gender
 Male4/63 (6.3)0.034
 Female6/28 (21.4)
Age (years)0.493b
Marital status
 Married10/76 (13.2)0.146
 Single/widowed/divorced0/15 (0.0)
Occupation
 None5/39 (12.8)0.625
 Others5/52 (9.6)
Educational level
 None5/26 (19.2)0.110
 Others5/65 (7.7)
Location of stroke
 Left hemisphere5/42 (11.9)0.873
 Right hemisphere5/47 (10.6)
TDQ0.011b
NIHSS0.045b
IADL0.067b
MMSE0.154b

Abbreviations: PSD: Poststroke depression; TDQ: Taiwanese Depression Screening Questionnaire; NIHSS: National Institutes of Health Stroke Scale; IADL: Instrumental activities of daily living scale; MMSE: Mini-mental status examination.

p values for the log-rank test.

Tested among quartile groups.

Table 3

Risk factors associated with PSD in Cox regression.

FactorsUnivariate model
Multivariate model 1
Multivariate model 2
HR (95% CI)pAdjusted HRa (95% CI)pAdjusted HRb (95% CI)p
Age1.00 (0.95–1.06)0.886
Female versus male3.52 (0.99–12.49)0.05115.51 (2.50–96.01)0.00315.95 (2.64–96.31)0.003
TDQ1.15 (1.08–1.24)<0.0011.26 (1.12–1.41)<0.0011.26 (1.12–1.41)<0.001
NIHSS1.22 (1.02–1.46)0.0301.46 (1.02–2.11)0.0411.52 (1.15–2.01)0.003
IADL0.91 (0.84–1.00)0.0450.98 (0.86–1.11)0.742
MMSE0.87 (0.75–1.01)0.060

Abbreviations: HR: Hazard ratio; CI: Confidence interval; TDQ: Taiwanese Depression Screening Questionnaire; NIHSS: National Institutes of Health Stroke Scale; IADL: Instrumental activities of daily living scale; MMSE: Mini-Mental Status Examination; PSD: Poststroke depression.

Multivariate model 1 included gender, TDQ, NIHSS, and IADL.

Multivariate model 2 included gender, TDQ, and NIHSS.

Table 4

Risk factors associated with PSD by gender.

FactorsUnivariate model
Multivariate model 1
Multivariate model 2
HR (95% CI)pAdjusted HRa (95% CI)pAdjusted HRb (95% CI)p
Female
 Age1.00 (0.93–1.07)0.990
 TDQ1.21 (1.03–1.42)0.0211.30 (1.09–1.56)0.004
 NIHSS1.33 (1.02–1.74)0.0371.70 (1.16–2.50)0.007
 IADL0.89 (0.79–1.01)0.080
 MMSE0.98 (0.82–1.17)0.836
Male
 Age1.02 (0.93–1.13)0.657
 TDQ1.20 (1.07–1.34)0.0021.18 (1.04–1.33)0.0091.20 (1.07–1.34)0.002
 NIHSS1.24 (0.95–1.63)0.111
 IADL0.94 (0.82–1.07)0.352
 MMSE0.73 (0.54–0.98)0.0350.82 (0.64–1.05)0.111

Abbreviations: HR: Hazard ratio; CI: Confidence interval; TDQ: Taiwanese Depression Screening Questionnaire; NIHSS: National Institutes of Health Stroke Scale; IADL: Instrumental activities of daily living scale; MMSE: Mini-mental status examination; PSD: Poststroke depression.

Female multivariate model 1 included TDQ and NIHSS, and male model 1 included TDQ and MMSE.

Male multivariate model 2 included TDQ only.

The related incidences of PSD by different demographic data and clinical assessment scores. Abbreviations: PSD: Poststroke depression; TDQ: Taiwanese Depression Screening Questionnaire; NIHSS: National Institutes of Health Stroke Scale; IADL: Instrumental activities of daily living scale; MMSE: Mini-mental status examination. p values for the log-rank test. Tested among quartile groups. Risk factors associated with PSD in Cox regression. Abbreviations: HR: Hazard ratio; CI: Confidence interval; TDQ: Taiwanese Depression Screening Questionnaire; NIHSS: National Institutes of Health Stroke Scale; IADL: Instrumental activities of daily living scale; MMSE: Mini-Mental Status Examination; PSD: Poststroke depression. Multivariate model 1 included gender, TDQ, NIHSS, and IADL. Multivariate model 2 included gender, TDQ, and NIHSS. Risk factors associated with PSD by gender. Abbreviations: HR: Hazard ratio; CI: Confidence interval; TDQ: Taiwanese Depression Screening Questionnaire; NIHSS: National Institutes of Health Stroke Scale; IADL: Instrumental activities of daily living scale; MMSE: Mini-mental status examination; PSD: Poststroke depression. Female multivariate model 1 included TDQ and NIHSS, and male model 1 included TDQ and MMSE. Male multivariate model 2 included TDQ only.

Discussion

In this study, the incidence rates of PSD in the 1st, 3rd, 6th, and 9th month were 4%, 8%, 9%, and 10%, respectively, and the overall incidence at 1 year was 11%. Female gender and higher TDQ and NIHSS scores were risk factors associated with PSD. Previous studies have reported that about 20%–40% of poststroke patients experience depressive symptoms [18], [31], [32], [33]. These discrepancies may be due to methodological heterogeneity, such as differences in the definition of stroke, the time of assessment after stroke, the diagnostic tools used to assess depression, the inclusion criteria, and the characteristics of the sample. In the present study, we used the DSM-IV diagnostic criteria of the major depressive episode to identify PSD, and this strict definition was also used in the studies from Hong Kong. Moreover, we excluded the patients with impairments in communication or cognitive function (MMSE score <15), out of concern for potential difficulties in conducting interviews, and history of depression, which has been reported to be a risk factor for PSD [22], [34], [35]. However, our study indicated the 1-year incidence of PSD rather than the prevalence, and thus it was difficult to compare our study with others. We found that the severity of stroke was not as great among patients with lower NIHSS scores. Our results indicate that stroke severity is highly correlated with the incidence of PSD, and this may be another reason why the incidence in the current study was lower than that in other studies. In addition, cultural differences may be another issue. Ethnic Chinese are not considered to be psychologically-minded – they tend to deny depression due to stigmatization and express depression in other ways, such as neurasthenia or somatization [36]. It has also been reported that many verbal expressions of feeling in the Chinese language do not clearly discriminate between physical complaints and emotional distress [37]. Together, these factors may interfere with the detection and identification of PSD; the incidence of PSD might have been higher if depression rating scales with more somatic items were used to identify PSD, instead of the DSM-IV diagnostic criteria. Because of the adverse effects of PSD, it is important to identify risk factors to allow for an early diagnosis and management, thereby decreasing the negative effects in stroke patients. We identified several risk factors associated with PSD, including female gender, stroke severity, and disability in daily living activities, which were consistent with previous studies [22], [24], [25], [38], [39], [40]; however, lesion laterality and educational level had no association with PSD, consistent with former studies [23], [39], [41]. Furthermore, being single, widowed, or divorced was not a risk factor for PSD in our study, in contrast to previous studies [39], [42]. This may be due to the small proportion of these patients and thus the inability to show a difference. As for depressive severity at baseline, we used the TDQ as an indicator of subclinical depressive symptoms. Higher depressive scores might lead to PSD afterward. In terms of clinical implications, clinicians should use the depression scale to screen ischemic stroke patients and then pay more attention to those with higher scores, since they might develop PSD. In addition, we also found some variations between male and female patients in the current study. The TDQ score was associated with PSD in both genders, so a higher depressive score at baseline predicted increased PSD,. However stroke severity in the NIHSS was significantly associated with PSD in the female group only. This suggests that the nature of PSD may differ in males and females. Gender differences in PSD were addressed in a systematic review study [43], which found that the prevalence of PSD was higher in females in most relevant studies. The postulated reasons for this included genetic factors, psychosocial issues, and the course-related to recovery [44]. Paradiso and Robinson reported that females are twice as likely to suffer from PSD as males and that this is due to more left hemisphere lesions occurring in females [45]. Further studies are needed to elucidate the exact relationship between gender and PSD. In spite of the lack of consistency regarding the peak incidence of PSD, most patients in our study developed PSD within the first 3 months, which is similar to previous reports [16], [17], [18]. Thus, stroke patients should be carefully monitored, especially in the first 3 months after stroke in order to detect PSD earlier and allow for interventions. There are several limitations to this study. First, enrolment did not include all stroke patients in the acute phase, and the most had mild severity. Therefore, the findings may not be applicable to all stroke patients. Second, this study was carried out in only one general hospital, so the results may not be generalized to other settings. Third, on the basis of exploratory analysis, our findings in present study need to be confirmed in further larger studies. Even so, we believe our findings are valuable. We addressed differences in risk factors between genders, which have not frequently been reported, and we found that the TDQ score and stroke severity may be predictors of PSD in stroke patients in Taiwan.

Conclusion

Our reported incidence of PSD was around 11% based on the criteria for major depressive episode in the DSM-IV. Given the negative impact of PSD, early detection and intervention are important. The clinical implication of our findings is that close observation of stroke patients and screening for depression are needed, especially during the first 3 months after stroke and in those with risk factors for PSD.

Source of support

The authors are very grateful to the research team for their dedication to this study and for grants from the Chang-Gung Medical Research Program (CMRPG 690493).

Conflicts of interest

None declared.
  45 in total

Review 1.  The association of late-life depression and anxiety with physical disability: a review of the literature and prospectus for future research.

Authors:  E J Lenze; J C Rogers; L M Martire; B H Mulsant; B L Rollman; M A Dew; R Schulz; C F Reynolds
Journal:  Am J Geriatr Psychiatry       Date:  2001       Impact factor: 4.105

2.  Poststroke depression among the Chinese elderly in a rural community.

Authors:  J L Fuh; H C Liu; S J Wang; C Y Liu; P N Wang
Journal:  Stroke       Date:  1997-06       Impact factor: 7.914

Review 3.  Sex differences in the prevalence of post-stroke depression: a systematic review.

Authors:  Brittany Poynter; Mira Shuman; Natalia Diaz-Granados; Moira Kapral; Sherry L Grace; Donna E Stewart
Journal:  Psychosomatics       Date:  2009 Nov-Dec       Impact factor: 2.386

4.  A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction.

Authors:  I Aben; F Verhey; J Strik; R Lousberg; J Lodder; A Honig
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

5.  Depressive symptoms following ischemic stroke: a study of 207 patients.

Authors:  Liang-Po Hsieh; Hui-Ju Kao
Journal:  Acta Neurol Taiwan       Date:  2005-12

6.  Longitudinal course of depressive symptomatology after a cardiac event: effects of gender and cardiac rehabilitation.

Authors:  Sherry L Grace; Susan E Abbey; Ruxandra Pinto; Zachary M Shnek; Jane Irvine; Donna E Stewart
Journal:  Psychosom Med       Date:  2005 Jan-Feb       Impact factor: 4.312

Review 7.  Depression in the planet's largest ethnic group: the Chinese.

Authors:  G Parker; G Gladstone; K T Chee
Journal:  Am J Psychiatry       Date:  2001-06       Impact factor: 18.112

8.  Frequency of depression after stroke: a systematic review of observational studies.

Authors:  Maree L Hackett; Chaturangi Yapa; Varsha Parag; Craig S Anderson
Journal:  Stroke       Date:  2005-05-05       Impact factor: 7.914

9.  Associated factors of post-stroke depression among Hong Kong Chinese: a longitudinal study.

Authors:  Janet W H Sit; Thomas K S Wong; Michael Clinton; Leonard S W Li
Journal:  Psychol Health Med       Date:  2007-03       Impact factor: 2.423

10.  Risk factors for post-stroke depression.

Authors:  G Andersen; K Vestergaard; M Ingemann-Nielsen; L Lauritzen
Journal:  Acta Psychiatr Scand       Date:  1995-09       Impact factor: 6.392

View more
  12 in total

1.  A sudden and severe depressive episode after a left cingulate gyrus stroke: a case report of post-stroke depression and review of literature.

Authors:  Nuno Filipe Ribeiro; Luís Madruga
Journal:  J Neural Transm (Vienna)       Date:  2021-04-07       Impact factor: 3.575

2.  Elevated Neutrophil-to-Lymphocyte Ratio Predicts Depression After Intracerebral Hemorrhage.

Authors:  Xiuqun Gong; Zeyu Lu; Xiwu Feng; Chuanqing Yu; Min Xue; Liang Yu; Tao Wang; Xiaosi Cheng; Jun Lu; Mei Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-09-21       Impact factor: 2.570

Review 3.  The advances of post-stroke depression: 2021 update.

Authors:  Jianglong Guo; Jinjing Wang; Wen Sun; Xinfeng Liu
Journal:  J Neurol       Date:  2021-05-30       Impact factor: 4.849

Review 4.  Risk Factors for Post-stroke Depression: A Meta-analysis.

Authors:  Yu Shi; Dongdong Yang; Yanyan Zeng; Wen Wu
Journal:  Front Aging Neurosci       Date:  2017-07-11       Impact factor: 5.750

5.  Prevalence, patterns and predictors of depression treatment among community-dwelling older adults with stroke in the United States: a cross sectional study.

Authors:  Sandipan Bhattacharjee; Majed Al Yami; Sawsan Kurdi; David Rhys Axon
Journal:  BMC Psychiatry       Date:  2018-05-16       Impact factor: 3.630

6.  Association between serum lipoprotein levels and neurological function in patients with acute ischemic stroke: A protocol of systematic review and meta-analysis.

Authors:  Yao-Jia Jiang; Zeng-Mian Wang; Ze-Yu Wang; Chun-Jie Wei
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

7.  Depressed Mood after Stroke: Predictive Factors at Six Months Follow-Up.

Authors:  Fidel López-Espuela; Raúl Roncero-Martín; Maria de la Luz Canal-Macías; Jose M Moran; Vicente Vera; Adela Gomez-Luque; Alejandro Lendinez-Mesa; Juan Diego Pedrera-Zamorano; Ignacio Casado-Naranjo; Jesus Lavado-García
Journal:  Int J Environ Res Public Health       Date:  2020-12-20       Impact factor: 3.390

8.  Longitudinal assessment of anxiety/depression rates and their related predictive factors in acute ischemic stroke patients: A 36-month follow-up study.

Authors:  Xin Liu; Chunmei Cheng; Zhaojun Liu; Wenjun Fan; Chunhua Liu; Yin Liu
Journal:  Medicine (Baltimore)       Date:  2021-12-17       Impact factor: 1.817

9.  Factors that influence the severity of post-stroke depression.

Authors:  S Ilut; A Stan; A Blesneag; V Vacaras; S Vesa; L Fodoreanu
Journal:  J Med Life       Date:  2017 Jul-Sep

10.  On the road to epigenetic therapy.

Authors:  Emma L Walton
Journal:  Biomed J       Date:  2016-08-31       Impact factor: 4.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.